Wikidata

(Q55609079)

English

TCR-engineered, customized, antitumor T cells for cancer immunotherapy: advantages and limitations.

scientific article published on 5 January 2011

In more languages

Statements

title
TCR-engineered, customized, antitumor T cells for cancer immunotherapy: advantages and limitations. (English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
5720046
retrieved
18 July 2018
reference URL
http://europepmc.org/abstract/PMC/5720046
main subject
T-lymphocytes
1 reference
stated in
PubMed
retrieved
12 October 2019
T-cell receptor
1 reference
stated in
PubMed
retrieved
15 December 2019
neoplasm
1 reference
stated in
PubMed
retrieved
8 February 2021
adoptive immunotherapy
1 reference
stated in
PubMed
retrieved
1 August 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q55609079&oldid=1766762653"